CompletedPHASE2, PHASE3NCT02509481
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Colorado State University
- Principal Investigator
- Brian D. Foy, PhDColorado State University
- Intervention
- Ivermectin(drug)
- Enrollment
- 2712 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2015
Study locations (2)
- Colorado State University, Fort Collins, Colorado, United States
- Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Houet, Burkina Faso
Collaborators
Institut de Recherche en Sciences de la Sante, Burkina Faso · Centre Muraz · Ministère de la Santé du Burkina Faso
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02509481 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.